Friday, August 27, 2004

Ambit Biosciences Raises $21M

San Diego-based Ambit Biosciences announced that it has raised a Series C funding of $21.0M led by Roche Venture Fund. The company is developing biopharmaceuticals based on a proprietary high throughput human kinase assay drug screening panel. Ambit is also backed by Avalon Ventures, Forward Ventures, GIMV, and Perseus-Soros BioPharmaceutical Fund. More information »

---